{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:51Z","timestamp":1786975611887,"version":"build-2736575974"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:p>\n                    This qualitative study examines whether patient-reported outcomes measures for acne incorporate LGBTQ\n                    <jats:sup>+<\/jats:sup>\n                    -inclusive language.\n                  <\/jats:p>","DOI":"10.1001\/jamadermatol.2024.5077","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T11:01:01Z","timestamp":1733310061000},"page":"108","source":"Crossref","is-referenced-by-count":3,"title":["LGBTQ+-Inclusive Language in Patient-Reported Outcome Measures for Acne Vulgaris"],"prefix":"10.1001","volume":"161","author":[{"given":"Twan","family":"Sia","sequence":"first","affiliation":[{"name":"Department of Dermatology, Stanford University School of Medicine, Redwood City, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Abou-Taleb","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stanford University School of Medicine, Redwood City, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howa","family":"Yeung","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia"},{"name":"Associate Editor, JAMA Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Lynn S.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Stanford University School of Medicine, Redwood City, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"7","key":"dld240026r1","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamadermatol.2024.1420","article-title":"Isotretinoin for acne in transgender and gender-diverse individuals receiving masculinizing hormone therapy.","volume":"160","author":"Choe","year":"2024","journal-title":"JAMA Dermatol"},{"issue":"5","key":"dld240026r2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jaad.2017.06.004","article-title":"Acne, sexual orientation, and mental health among young adults in the United States: a population-based, cross-sectional study.","volume":"77","author":"Gao","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"dld240026r3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jdv.14585","article-title":"Quality of life measurement in acne: position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.","volume":"32","author":"Chernyshov","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"dld240026r4","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1001\/jamadermatol.2022.2260","article-title":"Patient-reported outcome measures for health-related quality of life in patients with acne vulgaris: a systematic review of measure development and measurement properties.","volume":"158","author":"Hopkins","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"4","key":"dld240026r7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/bjd.20391","article-title":"Clinical experience and psychometric properties of the Cardiff Acne Disability Index (CADI).","volume":"185","author":"Abdelrazik","year":"2021","journal-title":"Br J Dermatol"},{"key":"dld240026r5","unstructured":"National Institutes of Health. Sex, gender, and sexuality. Accessed July 31, 2024. https:\/\/www.nih.gov\/nih-style-guide\/sex-gender-sexuality"},{"key":"dld240026r6","unstructured":"National Institutes of Health. LGBTIQ terminology. Accessed July 31, 2024. https:\/\/www.edi.nih.gov\/people\/sep\/lgbti\/safezone\/terminology"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2826500\/jamadermatology_sia_2024_ld_240026_1736781537.64471.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T11:01:14Z","timestamp":1736938874000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2826500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.5077","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}